Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F11%3A11008" target="_blank" >RIV/00216208:11110/11:11008 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/11:00055271 RIV/00216208:11120/11:00003391 RIV/00216208:11150/11:10107683 RIV/65269705:_____/11:#0001454 and 4 more
Result on the web
<a href="http://informahealthcare.com/doi/abs/10.3109/10428194.2011.573889" target="_blank" >http://informahealthcare.com/doi/abs/10.3109/10428194.2011.573889</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma
Original language description
This retrospective study evaluated the secondary clinical risk score at relapse, the prognostic significance of pre-transplant positron emission tomography (PET), and complete remission (CR) assessed by computed tomography (CT) after salvage chemotherapybefore autologous stem cell transplant (ASCT) in 76 patients with relapsed/refractory Hodgkin lymphoma (HL). Median follow-up after ASCT was 23 months. Overall 11/20 PET-positive and 14/56 PET-negative patients relapsed after ASCT. In univariate analysis, only PET negativity before ASCT was significantly associated with better 2-year progression-free survival (PFS) (72.7 +/- 6.3% vs. 36.1 +/- 11.6%, p = 0.01) and 2-year overall survival (OS) (90.3 +/- 4.1% vs. 61.4 +/- 11.6%, p = 0.009). Other factorswere not significant. In multivariate analysis, none of the evaluated factors were significant for PFS and OS. However, positive pre-transplant PET identified a population with worse PFS and OS at least in univariate analysis.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia & Lymphoma
ISSN
1042-8194
e-ISSN
—
Volume of the periodical
52
Issue of the periodical within the volume
9
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
1668-1674
UT code for WoS article
000294228100010
EID of the result in the Scopus database
—